Physician profile
Shereelah Deen
NPI 1649287756
$1,037.57
in general payments reported to CMS, 2019-2025
14 companies · $91.49 in 2025
The $91.49 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $67.14 · 2021: $14.93 · 2022: $329 · 2023: $130 · 2025: $91.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $461.11 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $120.91 | 2019-2020 | |
| Embecta Corp. | $62.70 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Lilly USA, LLC | $42.50 | 2019-2021 | |
| Glaxosmithkline, LLC. | $39.53 | 2019-2023 | Shingrix |
| Gilead Sciences, INC. | $30.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.42 | 2019 | |
| Novo Nordisk INC | $28.36 | 2019 | |
| Astellas Pharma US INC | $26.73 | 2019 | |
| Medtronic USA, INC. | $25.24 | 2019-2020 | |
| Abbott Laboratories | $20.45 | 2019 | |
| Hikma Pharmaceuticals USA | $15.00 | 2020 | |
| Pfizer INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shereelah Deen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.